Get startedLog in
    Picture of Laboratorios Farmaceuticos Rovi SA logo

    ROVI — Laboratorios Farmaceuticos Rovi SA Cashflow Statement

    0.000.00%
    es flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Laboratorios Farmaceuticos Rovi SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line72.6183258220178
    Depreciation
    Amortisation
    Non-Cash Items1.77-1.60.1371.960.926
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-47.1-53-43.4-133-68.4
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Payable / Accrued Expenses
    Other Operating Cash Flow
    Cash from Operating Activities46.9149238113138
    Capital Expenditures-39.7-40.9-51.4-55.2-62.2
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.0670.101-5.773.16-18.8
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-39.6-40.8-57.2-52-81.1
    Financing Cash Flow Items-0.299-0.2881.082.393.64
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-21.5-62.7-155-161-55.4
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-14.345.925.9-99.61.86